Anixa Biosciences Inc (ANIX)
2.99
-0.10
(-3.24%)
USD |
NASDAQ |
May 02, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences Price: 2.99 for May 2, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 02, 2024 | 3.09 | 3.101 | 2.98 | 2.99 | 51448.00 |
May 01, 2024 | 2.98 | 3.15 | 2.98 | 3.09 | 58633.00 |
Apr 30, 2024 | 3.03 | 3.086 | 2.915 | 2.97 | 117723.0 |
Apr 29, 2024 | 3.22 | 3.25 | 3.02 | 3.02 | 158338.0 |
Apr 26, 2024 | 3.15 | 3.319 | 3.13 | 3.23 | 237328.0 |
Apr 25, 2024 | 3.25 | 3.32 | 2.94 | 2.98 | 251933.0 |
Apr 24, 2024 | 3.22 | 3.400 | 3.04 | 3.18 | 357353.0 |
Apr 23, 2024 | 3.03 | 3.12 | 3.00 | 3.07 | 73542.00 |
Apr 22, 2024 | 3.16 | 3.16 | 3.01 | 3.01 | 57975.00 |
Apr 19, 2024 | 3.10 | 3.20 | 3.05 | 3.12 | 32692.00 |
Apr 18, 2024 | 3.08 | 3.13 | 3.03 | 3.10 | 58503.00 |
Apr 17, 2024 | 3.19 | 3.200 | 3.05 | 3.05 | 72904.00 |
Apr 16, 2024 | 3.17 | 3.250 | 3.15 | 3.17 | 78207.00 |
Apr 15, 2024 | 3.20 | 3.235 | 3.150 | 3.16 | 99028.00 |
Apr 12, 2024 | 3.23 | 3.23 | 3.165 | 3.17 | 50947.00 |
Apr 11, 2024 | 3.22 | 3.25 | 3.20 | 3.22 | 33709.00 |
Apr 10, 2024 | 3.24 | 3.424 | 3.17 | 3.20 | 60338.00 |
Apr 09, 2024 | 3.17 | 3.350 | 3.167 | 3.25 | 53078.00 |
Apr 08, 2024 | 3.18 | 3.214 | 3.117 | 3.17 | 40735.00 |
Apr 05, 2024 | 3.16 | 3.26 | 3.09 | 3.20 | 100478.0 |
Apr 04, 2024 | 3.25 | 3.305 | 3.09 | 3.14 | 61964.00 |
Apr 03, 2024 | 3.24 | 3.29 | 3.095 | 3.28 | 92723.00 |
Apr 02, 2024 | 3.34 | 3.34 | 3.16 | 3.20 | 43067.00 |
Apr 01, 2024 | 3.18 | 3.48 | 3.06 | 3.35 | 182640.0 |
Mar 28, 2024 | 3.21 | 3.390 | 3.08 | 3.12 | 123508.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.35
Minimum
Mar 27 2020
7.14
Maximum
Mar 17 2021
3.666
Average
3.69
Median
Jul 13 2021
Price Benchmarks
CEL-SCI Corp | 1.48 |
AIM ImmunoTech Inc | 0.4042 |
IGC Pharma Inc | 0.52 |
NovaBay Pharmaceuticals Inc | 0.09 |
Protalix BioTherapeutics Inc | 1.16 |
Price Related Metrics
Price to Book Value | 3.876 |
Earnings Yield | -11.37% |
Market Cap | 95.38M |